Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
ID: 350632Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $750K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350632

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-003.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs) under the funding opportunity RFA-DK-25-003. This initiative aims to enhance collaboration among basic and clinical researchers focused on digestive and liver diseases by providing shared resources that foster productivity and innovation, with each center organized around a central theme aligned with the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Applicants must demonstrate a robust research base with a minimum of $3 million in direct costs per year from federally funded projects, including a mandatory Plan for Enhancing Diverse Perspectives (PEDP) and a strong administrative structure. Approximately $4.8 million is available for four new awards each year, with a maximum budget of $750,000 in direct costs per year over a five-year period. The application submission cycle opens on January 22, 2024, with reviews commencing shortly thereafter. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DK-25-003-Full-Announcement.html
    RFA-DK-25-003.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), invites applications for the Silvio O. Conte Digestive Diseases Research Core Centers (DDRCCs) under the funding opportunity RFA-DK-25-003. This initiative aims to foster collaboration among basic and clinical researchers focused on digestive and liver diseases. DDRCCs enable shared resources to enhance research synergy and productivity, requiring a central theme aligned with the NIDDK’s mission. Applicants must demonstrate an active research base, with a minimum of $3 million in direct costs per year from federally funded projects, at least 30% of which must come from NIDDK. A Plan for Enhancing Diverse Perspectives (PEDP) is mandatory for applications and will be assessed during peer review. Each center must include a strong administrative structure to coordinate activities and evaluate performance. Proposed cores should provide unique services that cannot be easily sourced from commercial providers and must include robust quality control measures. Funding of approximately $4.8 million is set for four new awards each year, with a maximum budget of $750,000 in direct costs per year over a five-year period. The application submission cycle opens on January 22, 2024, with reviews beginning shortly thereafter.
    Similar Opportunities
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01), aimed at supporting investigator-initiated, high-risk clinical trials that involve multiple clinical centers. Applicants must propose hypothesis-driven studies that focus on diseases relevant to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), with an emphasis on enhancing diverse perspectives in research. This funding opportunity is crucial for advancing therapeutic studies that can significantly improve clinical practices and public health outcomes. Interested applicants should note that the application period opens on January 5, 2024, with a closing date of November 5, 2026, and are encouraged to consult with NIDDK staff prior to submission. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)" aimed at supporting innovative research that addresses significant knowledge gaps within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This initiative encourages interdisciplinary approaches to foster advancements in understanding, treating, and preventing diseases related to diabetes, digestive, and kidney disorders, with a focus on generating impactful research resources and hypothesis-generating science. Eligible applicants include a wide range of institutions such as higher education entities, nonprofits, for-profits, and various governmental agencies, with project durations extending up to five years initially and a total funding period of up to ten years. Interested parties should note that the application deadline is October 30, 2024, and are encouraged to contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity for high-risk multi-center clinical study implementation planning via Cooperative Agreements (U34). This initiative aims to support the early peer review of proposed clinical studies, assess study designs, and develop essential documentation, including operational manuals, focusing on diseases relevant to NIDDK's mission. The program emphasizes health equity and inclusivity, requiring a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Interested applicants can apply for up to $225,000 per year for a maximum of two years, with the application submission period opening on September 9, 2024, and the closing date set for June 10, 2027. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    Central Coordinating Site for the Polycystic Kidney Disease Research Core Centers (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the Central Coordinating Site (CCS) for the Polycystic Kidney Disease (PKD) Research Core Centers through Funding Opportunity Number RFA-DK-25-015. The CCS will collaborate with four PKD Research Core Centers to enhance understanding of PKD and promote resource sharing, providing essential administrative support, managing data sharing, and administering pilot project funding. This initiative is crucial for fostering a diverse and collaborative research environment to address the challenges of PKD effectively. The funding opportunity anticipates approximately $1.1 million for one award in FY 2025, with annual budgets around $350,000. Interested applicants must submit their proposals via Grants.gov by November 14, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01), aimed at supporting high-risk observational studies related to diabetes, digestive, kidney, and metabolic diseases. Applicants must complete all planning activities prior to submission, as these cannot be included in the U01 application, and a Plan for Enhancing Diverse Perspectives (PEDP) is mandatory for consideration. This funding opportunity is crucial for advancing clinical research and addressing health disparities, particularly by encouraging collaboration with underrepresented communities. Interested applicants should note that the application deadline is February 5, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Single Source for Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a cooperative agreement for the establishment of the Chronic Pancreatitis Clinical Research Consortium Data Coordinating Center (CPCRC-DCC) under funding opportunity RFA-DK-25-020. The primary objective is to facilitate ongoing studies on chronic pancreatitis, diabetes, and pancreatic cancer, focusing on data management, biomarker development, and clinical trial support for both pediatric and adult populations. This initiative is crucial for advancing the understanding of chronic pancreatitis and its associations with diabetes and pancreatic cancer, with an anticipated funding amount of $6.5 million over five years. Interested applicants must submit their proposals by 5:00 PM on October 19, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    The Chronic Pancreatitis Clinical Research Consortium (CPCRC)- Clinical Centers (CPCRC-CCs) (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Chronic Pancreatitis Clinical Research Consortium (CPCRC), inviting U01 applications for Clinical Centers to conduct research on chronic pancreatitis, diabetes, and pancreatic cancer. The initiative aims to continue the consortium's work by collecting clinical data and biospecimens to identify biomarkers for risk stratification and disease progression, ultimately enhancing understanding and treatment of these conditions. With an estimated funding of $6.5 million for the 2025 fiscal year, applications are due by October 18, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Nutrition Obesity Research Centers Research Resource Center (RRC) (P2C- Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has announced a funding opportunity for the establishment of a Nutrition Obesity Research Centers (NORC) Research Resource Center (RRC). This grant aims to enhance nutrition and obesity research by providing administrative support, managing collaborative programs, and promoting workforce diversity, particularly for early-to-mid-career researchers from diverse backgrounds. The initiative is critical for addressing health disparities related to obesity and will support a range of activities, including the management of pilot and feasibility studies, with funding set at approximately $1 million over a maximum five-year period, including a direct cost cap of $625,000 for the first year. Interested applicants must submit their proposals by October 9, 2024, and include a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application, with further inquiries directed to grantsinfo@nih.gov.
    NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering Research Education Program Grants (R25) to enhance training in biomedical, behavioral, and clinical research. This funding opportunity aims to support educational activities that develop research skills and provide hands-on experiences in areas critical to NIDDK, including diabetes, digestive diseases, and obesity. Eligible applicants include a wide range of organizations such as higher education institutions, non-profits, and local governments, with a funding limit of $100,000 per year for up to five years. The application deadline is January 30, 2024, and interested parties can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the program's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-074.html.
    Polycystic Kidney Disease Core Centers (U54 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Polycystic Kidney Disease (PKD) Core Centers through a Notice of Funding Opportunity (NOFO) aimed at enhancing national research efforts in PKD. The initiative seeks to establish four Core Centers that will collaborate within the PKD Research Resource Consortium, focusing on developing and sharing essential research tools and resources while promoting scientific diversity and engagement among a wide range of investigators. Approximately $3.44 million in funding is anticipated for FY 2025, with applications due by November 15, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.